Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) FCF Margin: 2015-2025

Historic FCF Margin for Wave Life Sciences (WVE) over the last 7 years, with Jun 2025 value amounting to -532.45%.

  • Wave Life Sciences' FCF Margin fell 39270.00% to -532.45% in Q2 2025 from the same period last year, while for Jun 2025 it was -399.40%, marking a year-over-year decrease of 28210.00%. This contributed to the annual value of -140.32% for FY2024, which is 12218.00% down from last year.
  • Per Wave Life Sciences' latest filing, its FCF Margin stood at -532.45% for Q2 2025, which was up 22.71% from -688.87% recorded in Q1 2025.
  • Wave Life Sciences' FCF Margin's 5-year high stood at 657.69% during Q1 2023, with a 5-year trough of -9,158.95% in Q3 2022.
  • For the 3-year period, Wave Life Sciences' FCF Margin averaged around -166.03%, with its median value being -154.31% (2023).
  • Its FCF Margin has fluctuated over the past 5 years, first plummeted by 908,130bps in 2022, then soared by 908,853bps in 2023.
  • Quarterly analysis of 5 years shows Wave Life Sciences' FCF Margin stood at -399.32% in 2021, then plummeted by 231,610bps to -2,715.42% in 2022, then soared by 259,979bps to -115.62% in 2023, then skyrocketed by 2,911bps to -139.75% in 2024, then crashed by 39,270bps to -532.45% in 2025.
  • Its FCF Margin stands at -532.45% for Q2 2025, versus -688.87% for Q1 2025 and -139.75% for Q2 2024.